BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

457 related articles for article (PubMed ID: 19417680)

  • 1. Atypical familial presentation of FAMMM syndrome with a high incidence of pancreatic cancer: case finding of asymptomatic individuals by EUS surveillance.
    Kluijt I; Cats A; Fockens P; Nio Y; Gouma DJ; Bruno MJ
    J Clin Gastroenterol; 2009 Oct; 43(9):853-7. PubMed ID: 19417680
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Is endoscopic ultrasound "sound" for pancreatic cancer screening?
    Bhutani MS; Verma D; Guha S; Lee JH; Richards-Kortum RR; Fleming JB
    J Clin Gastroenterol; 2009 Oct; 43(9):797-802. PubMed ID: 19652621
    [No Abstract]   [Full Text] [Related]  

  • 3. The yield of first-time endoscopic ultrasonography in screening individuals at a high risk of developing pancreatic cancer.
    Poley JW; Kluijt I; Gouma DJ; Harinck F; Wagner A; Aalfs C; van Eijck CH; Cats A; Kuipers EJ; Nio Y; Fockens P; Bruno MJ
    Am J Gastroenterol; 2009 Sep; 104(9):2175-81. PubMed ID: 19491823
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Risk of developing pancreatic cancer in families with familial atypical multiple mole melanoma associated with a specific 19 deletion of p16 (p16-Leiden).
    Vasen HF; Gruis NA; Frants RR; van Der Velden PA; Hille ET; Bergman W
    Int J Cancer; 2000 Sep; 87(6):809-11. PubMed ID: 10956390
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Phenotypic variation in eight extended CDKN2A germline mutation familial atypical multiple mole melanoma-pancreatic carcinoma-prone families: the familial atypical mole melanoma-pancreatic carcinoma syndrome.
    Lynch HT; Brand RE; Hogg D; Deters CA; Fusaro RM; Lynch JF; Liu L; Knezetic J; Lassam NJ; Goggins M; Kern S
    Cancer; 2002 Jan; 94(1):84-96. PubMed ID: 11815963
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Pancreatic cancer-associated gene polymorphisms in a nation-wide cohort of p16-Leiden germline mutation carriers; a case-control study.
    Potjer TP; van der Stoep N; Houwing-Duistermaat JJ; Konings IC; Aalfs CM; van den Akker PC; Ausems MG; Dommering CJ; van der Kolk LE; Maiburg MC; Spruijt L; Wagner A; Vasen HF; Hes FJ
    BMC Res Notes; 2015 Jun; 8():264. PubMed ID: 26111702
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Short-term Results of a Magnetic Resonance Imaging-Based Swedish Screening Program for Individuals at Risk for Pancreatic Cancer.
    Del Chiaro M; Verbeke CS; Kartalis N; Pozzi Mucelli R; Gustafsson P; Hansson J; Haas SL; Segersvärd R; Andren-Sandberg Å; Löhr JM
    JAMA Surg; 2015 Jun; 150(6):512-8. PubMed ID: 25853369
    [TBL] [Abstract][Full Text] [Related]  

  • 8. AGA Clinical Practice Update on Pancreas Cancer Screening in High-Risk Individuals: Expert Review.
    Aslanian HR; Lee JH; Canto MI
    Gastroenterology; 2020 Jul; 159(1):358-362. PubMed ID: 32416142
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Results of First-Round of Surveillance in Individuals at High-Risk of Pancreatic Cancer from the AISP (Italian Association for the Study of the Pancreas) Registry.
    Paiella S; Capurso G; Cavestro GM; Butturini G; Pezzilli R; Salvia R; Signoretti M; Crippa S; Carrara S; Frigerio I; Bassi C; Falconi M; Iannicelli E; Giardino A; Mannucci A; Laghi A; Laghi L; Frulloni L; Zerbi A
    Am J Gastroenterol; 2019 Apr; 114(4):665-670. PubMed ID: 30538291
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Macrophage inhibitory cytokine-1/growth differentiation factor-15 in premalignant and neoplastic tumours in a high-risk pancreatic cancer cohort.
    O'Neill RS; Emmanuel S; Williams D; Stoita A
    World J Gastroenterol; 2020 Apr; 26(14):1660-1673. PubMed ID: 32327914
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Screening for pancreatic neoplasia in high-risk individuals: an EUS-based approach.
    Canto MI; Goggins M; Yeo CJ; Griffin C; Axilbund JE; Brune K; Ali SZ; Jagannath S; Petersen GM; Fishman EK; Piantadosi S; Giardiello FM; Hruban RH
    Clin Gastroenterol Hepatol; 2004 Jul; 2(7):606-21. PubMed ID: 15224285
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Role of endoscopic ultrasound in the screening and follow-up of high-risk individuals for familial pancreatic cancer.
    Lorenzo D; Rebours V; Maire F; Palazzo M; Gonzalez JM; Vullierme MP; Aubert A; Hammel P; Lévy P; de Mestier L
    World J Gastroenterol; 2019 Sep; 25(34):5082-5096. PubMed ID: 31558858
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Strategies for screening for pancreatic adenocarcinoma in high-risk patients: the place of endoscopic ultrasound].
    Béchade D
    Presse Med; 2011 Mar; 40(3):230-8. PubMed ID: 21211938
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Benefit of Surveillance for Pancreatic Cancer in High-Risk Individuals: Outcome of Long-Term Prospective Follow-Up Studies From Three European Expert Centers.
    Vasen H; Ibrahim I; Ponce CG; Slater EP; Matthäi E; Carrato A; Earl J; Robbers K; van Mil AM; Potjer T; Bonsing BA; de Vos Tot Nederveen Cappel WH; Bergman W; Wasser M; Morreau H; Klöppel G; Schicker C; Steinkamp M; Figiel J; Esposito I; Mocci E; Vazquez-Sequeiros E; Sanjuanbenito A; Muñoz-Beltran M; Montans J; Langer P; Fendrich V; Bartsch DK
    J Clin Oncol; 2016 Jun; 34(17):2010-9. PubMed ID: 27114589
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Update on familial pancreatic cancer.
    Lynch HT; Brand RE; Deters CA; Fusaro RM
    Curr Gastroenterol Rep; 2001 Apr; 3(2):121-8. PubMed ID: 11276379
    [TBL] [Abstract][Full Text] [Related]  

  • 16. New strategies for the early detection of pancreatic cancer.
    Petrone MC; Arcidiacono PG
    Expert Rev Gastroenterol Hepatol; 2016; 10(2):157-9. PubMed ID: 26582179
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Promising outcomes of screening for pancreatic cancer by genetic testing and endoscopic ultrasound.
    Sud A; Wham D; Catalano M; Guda NM
    Pancreas; 2014 Apr; 43(3):458-61. PubMed ID: 24622079
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Pancreatic cancer screening in high-risk individuals with germline genetic mutations.
    DaVee T; Coronel E; Papafragkakis C; Thaiudom S; Lanke G; Chakinala RC; Nogueras González GM; Bhutani MS; Ross WA; Weston BR; Lee JH
    Gastrointest Endosc; 2018 Jun; 87(6):1443-1450. PubMed ID: 29309780
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Five years of prospective screening of high-risk individuals from families with familial pancreatic cancer.
    Langer P; Kann PH; Fendrich V; Habbe N; Schneider M; Sina M; Slater EP; Heverhagen JT; Gress TM; Rothmund M; Bartsch DK
    Gut; 2009 Oct; 58(10):1410-8. PubMed ID: 19470496
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Frequent detection of pancreatic lesions in asymptomatic high-risk individuals.
    Canto MI; Hruban RH; Fishman EK; Kamel IR; Schulick R; Zhang Z; Topazian M; Takahashi N; Fletcher J; Petersen G; Klein AP; Axilbund J; Griffin C; Syngal S; Saltzman JR; Mortele KJ; Lee J; Tamm E; Vikram R; Bhosale P; Margolis D; Farrell J; Goggins M;
    Gastroenterology; 2012 Apr; 142(4):796-804; quiz e14-5. PubMed ID: 22245846
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 23.